Rogers Campbell 4

What Happened

• Rogers Campbell, Chief Medical Officer of Heartflow (HTFL), exercised stock options on March 19, 2026 to acquire 67,017 shares at an exercise price of $2.22 per share (total cost ≈ $148,777). He sold 64,533 shares in an open‑market transaction that day for a weighted average price of $25.69, generating proceeds of $1,658,033. The sale included 16,918 shares he already held and the option exercise and sale of 47,615 shares.

Key Details

• Transaction date: March 19, 2026; Form filed: March 23, 2026 (timely — filed within two business days).
• Exercise price: $2.22 per share; total exercise cost ≈ $148,777.
• Sale: 64,533 shares at weighted avg $25.69 (trade prices ranged $25.00–$28.00); proceeds $1,658,033.
• Footnotes: transactions were effected under a Rule 10b5‑1 trading plan adopted Sept 12, 2025 (F1–F3). The filing notes multiple trades and provides a weighted average sale price (F4). Option vests in monthly installments through July 1, 2027 (F5).
• Derivative reporting: the filing also shows derivative disposals reported at $0.00 in connection with the option activity (per the Form).
• Shares owned after the transaction: not disclosed in the provided excerpt of the filing.

Context

• This was an option exercise followed by a prompt sale of shares (common practice to realize value or cover exercise/tax obligations). The transactions were executed pursuant to a pre‑arranged 10b5‑1 plan, meaning the trades were pre‑planned rather than ad hoc. This is primarily a liquidity event (sale) rather than a fresh insider purchase.